TABLE 2.
Characteristics of HRS participants in the APOE4 subsample who lived up to age ≥80.
| HRS | Men | Women | Total | |||
|---|---|---|---|---|---|---|
| APOE4 carrier | No | Yes | No | Yes | No | Yes |
| N | 1,655 | 576 | 2,331 | 805 | 3,986 | 1,381 |
| Continuous variables: mean (standard deviation) | ||||||
| Entry age | 65.41 (7.38) | 65.22 (7.32) | 65.89 (7.47) | 65.13 (7.28) | 65.69 (7.44) | 65.17 (7.30) |
| End of follow-up age | 86.60 (4.72) | 86.12 (4.44) | 87.48 (5.34) | 86.76 (5.06) | 87.11 (5.11) | 86.49 (4.82) |
| Birth cohort | 1,928.69 (5.97) | 1,929.08 (5.63) | 1,928.32 (6.38) | 1,928.95 (6.17) | 1,928.48 (6.21) | 1,929.00 (5.95) |
| Dichotomous variables: N (percentage): number and percentage of individuals in group “1” | ||||||
| Education, Highschool+ | 1,446 (87.37) | 488 (84.87) | 2,064 (88.55) | 722 (89.69) | 3,510 (88.06) | 1,210 (87.68) |
| Ever smoked | 1,121 (68.52) | 401 (70.47) | 1,001 (43.17) | 354 (44.19) | 2,122 (53.65) | 755 (55.11) |
| AgeMaxW | 562 (37.24) | 179 (33.65) | 848 (40.57) | 239 (32.34) | 1,410 (3,918) | 418 (32.89) |
| SlopeW | 705 (51.31) | 225 (46.20) | 990 (52.83) | 292 (43.00) | 1,695 (52.19) | 517 (44.34) |
| Survival85 | 929 (79.40) | 315 (76.64) | 1,411 (86.67) | 444 (81.02) | 2,340 (83.63) | 759 (79.14) |
| Race: Black | 143 (8.64) | 65 (11.28) | 239 (10.25) | 125 (15.53) | 382 (9.58) | 190 (13.76) |
| Race: White | 1,374 (83.02) | 466 (80.90) | 1,868 (80.14) | 624 (77.52) | 3,242 (81.33) | 1,090 (78.93) |
| Cancer | 603 (36.44) | 210 (36.46) | 630 (27.03) | 223 (27.70) | 1,233 (30.93) | 433 (31.35) |
| Cardiovascular disease | 1,082 (65.38) | 366 (63.54) | 1,236 (53.02) | 452 (56.15) | 2,318 (58.15) | 818 (59.23) |